Stuart Cobb alongside Reverse Rett Executive Director, Rachael Bloom at the British Society for Gene and Cell Therapy Conference in April 2013
We are delighted to announce that Stuart Cobb, Head of the Neurophysiology lab at The University of Glasgow, has joined our Professional Advisory Board. Stuart was the co-author on 2007 reversal paper with Adrian Bird which took interest in Rett research to new levels. More recently he has joined other respected Rett researchers, Gail Mandel, Brian Kaspar and Steven Gray as part of an international consortium developing gene therapy as a potential therapeutic approach to treating Rett Syndrome.
Stuart says 'I was first introduced to Rett Syndrome when I received an out of the blue phone call from Adrian Bird, who first discovered MeCP2 protein, requesting some help with a set of specific experiments. Following this successful collaboration, Rett syndrome research has become a primary focus of my lab.'
Stuart has long been an advocate of Gene Therapy and is very excited about being involved with the newly formed MECP2 Gene Therapy Consortium.
He continues, 'While traditional drug approaches will likely be restricted to correcting specific aspects of what goes wrong in Rett, it is conceivable that Gene Therapy can correct the cause of Rett at it's very source and thus provide a profound recovery of function.'
'I'm honoured to join the Professional Advisory Board at Reverse Rett and I'm sure my knowledge of Rett Syndrome and of the global efforts aimed at finding treatments for the disorder can help Reverse Rett to develop their strategies for raising awareness, funding and scientific advocacy.'
We are extremely grateful to Stuart for taking the time to help us grow the charity and for all he has done and continues to do to help our children.